These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 9989456)

  • 1. Oxidative alterations in Alzheimer's disease.
    Markesbery WR; Carney JM
    Brain Pathol; 1999 Jan; 9(1):133-46. PubMed ID: 9989456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress hypothesis in Alzheimer's disease.
    Markesbery WR
    Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.
    Sultana R; Butterfield DA
    Neurochem Res; 2004 Dec; 29(12):2215-20. PubMed ID: 15672542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.
    Sultana R; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2006; 8(11-12):2021-37. PubMed ID: 17034347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.
    Markesbery WR; Lovell MA
    Neurobiol Aging; 1998; 19(1):33-6. PubMed ID: 9562500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
    Butterfield DA; Castegna A; Lauderback CM; Drake J
    Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.
    Butterfield DA; Drake J; Pocernich C; Castegna A
    Trends Mol Med; 2001 Dec; 7(12):548-54. PubMed ID: 11733217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
    Butterfield DA; Lauderback CM
    Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.
    Lovell MA; Xie C; Markesbery WR
    Neurobiol Aging; 2001; 22(2):187-94. PubMed ID: 11182468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
    Singh M; Dang TN; Arseneault M; Ramassamy C
    J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
    Calingasan NY; Uchida K; Gibson GE
    J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
    Lovell MA; Markesbery WR
    J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.
    Lovell MA; Gabbita SP; Markesbery WR
    J Neurochem; 1999 Feb; 72(2):771-6. PubMed ID: 9930752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.
    Cioffi F; Adam RHI; Bansal R; Broersen K
    J Alzheimers Dis; 2021; 83(3):977-1001. PubMed ID: 34420962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.